Bio Solution Co.,Ltd. (KOSDAQ: A086820)
Health Care · Biotechnology · KR
₩6,730.00
+0.90% today · -25.6% 1Y
Bio Solution Co.,Ltd. (KOSDAQ: A086820) operates in the Biotechnology industry within the Health Care sector. The company is valued at $125.31M.
Over the last twelve months the share price has lost 25.6%, trading between 5.24K and 13.45K.
Tweenvest scores Bio Solution Co.,Ltd. across four factors: quality 40/100, value 54/100. Its strongest factor is value.
A086820 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $125.31M
- Revenue (TTM)
- $10.40M
- P/E
- 249.15
- EPS
- 27.01
- Dividend yield
- —
- Beta (5Y)
- -0.14
- 52-week high
- ₩13,450.00
- 52-week low
- ₩5,240.00
- Avg volume (3M)
- —
- Shares outstanding
- 25.80M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $467.44B | $264.08 | -0.17% |
| Amgen Inc.NasdaqGS: AMGN | $239.95B | $442.95 | -0.20% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.95B | $146.37 | -0.26% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.79B | $545.46 | -0.39% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $82.73B | $826.01 | -0.30% |
| argenx SEENXTBR: ARGX | $63.06B | €872.20 | +0.93% |
| CSL LimitedASX: CSL | $57.94B | AU$169.11 | +0.48% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $144.03 | +3.70% |
Figures last refreshed Aug 18, 2026.